Cogent Biosciences Inc.

COGT | NASDAQ

Price Alert Chart Builder DCF Calculator

$32

+$0.50 (+1.59%)

At close: Sep 21, 2026, 4:00 PM ET

$32.25

+$0.25 (+0.78%)

Pre-market: Sep 22, 2026, 4:42 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $5.38B

Enterprise Value $4.92B

Beta 0.31

Average Volume 2.21M

Shares Outstanding (Diluted) 171.01M

Shares Change YoY 50.1%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US19240Q2012

Price Performance

Price Change 1M -13.0%

Price Change 3M -11.9%

Price Change 6M -12.3%

Price Change YTD -7.9%

Price Change 1Y 155.8%

Price Change 3Y 219.4%

Price Change 5Y 271.7%

1M CAGR (ann.) -24.6%

1Y CAGR (ann.) 154.8%

5Y CAGR (ann.) 30.2%

All-Time CAGR -4.0%

Valuation

PE Ratio -13.85

Forward PE N/A

PEG Ratio -1.50

Forward PEG 0.25

PS Ratio N/A

Forward PS 18.70

PB Ratio 10.27

P/FCF Ratio -17.68

P/Adj. FCF Ratio -14.79

P/OCF Ratio -17.78

EV/Sales N/A

EV/EBIT -13.07

EV/EBITDA -13.19

EV/FCF -15.91

Earnings Yield -7.2%

FCF Yield -5.7%

Adj. FCF Yield -6.8%

Financial Health

Net Cash $567.35M

Total Debt $244.26M

Cash & Short-Term Investments $792.3M

Total Assets $834.55M

Current Ratio 13.57

Quick Ratio 13.57

Debt / Equity Ratio 0.46

Debt / EBITDA -0.66

Debt / FCF -0.79

OCF / Debt -1.26

Interest Coverage -75.14

Altman Z-Score 7.95

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -19.5%

Returns

Return on Assets -45.2%

Return on Equity -72.6%

Return on Invested Capital -50.1%

Return on Capital Employed -50.2%

Return on Tangible Assets -45.2%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y -26.5%

EPS CAGR 3Y 3.5%

EPS CAGR 5Y -1.1%

EPS CAGR 10Y 6.8%

FCF CAGR 3Y -27.3%

FCF CAGR 5Y -27.4%

FCF CAGR 10Y -27.1%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 12

EPS Growth Next 3Y 77.2%

Revenue Growth Next 3Y N/A

Earnings Date N/A

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $51.75

Price Target Upside 61.7%

Cash Flow

Operating Cash Flow $-307.55M

Free Cash Flow $-309.24M

Adj. Free Cash Flow $-369.61M

FCF Per Share -$1.81

OCF Per Share -$1.80

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-2.33M

Operating Income $-389.09M

EBITDA $-372.86M

Net Income $-377.18M

EPS (Diluted) -$2.31

Revenue / Employee N/A

Profit / Employee $-1.46M

Employees 258